Self-iterative multiple-instance learning enables the prediction of CD4+ T cell immunogenic epitopes
Open Access
- 10 July 2025
- journal article
- research article
- Published by Springer Nature in Nature Machine Intelligence
- Vol. 7 (8) , 1250-1265
Abstract
Accurate prediction of antigen presentation to CD4+ T cells and subsequent induction of immune response are fundamentally important for vaccine development, autoimmune disease treatment and cancer neoepitope discovery. In immunopeptidomics, single-allelic data offer high specificity but limited allele coverage, whereas multi-allelic data provide broader representation at the expense of weak labelling. Current computational approaches either overlook the abundance of multi-allelic data or suffer from label ambiguity due to inadequate modelling strategies. To address these limitations, we present ImmuScope, a weakly supervised deep learning framework that integrates major histocompatibility complex class II (MHC-II) antigen presentation, CD4+ T cell epitopes and immunogenicity assessment. ImmuScope leverages self-iterative multiple-instance learning with positive-anchor triplet loss to decipher peptide-MHC-II binding from weakly labelled multi-allelic data and high-confidence single-allelic data. The training dataset comprises over 600,000 ligands across 142 alleles. Additionally, ImmuScope enables the interpretation of MHC-II binding specificity and motif deconvolution of immunopeptidomics data. We successfully applied ImmuScope to identify melanoma neoantigens, uncovering mutation-driven variations in peptide-MHC-II binding and immunogenicity. Furthermore, we employed ImmuScope to evaluate the effects of SARS-CoV-2 epitope mutations associated with immune escape, with predictions well aligned with experimentally observed immune escape dynamics. Overall, by offering a unified solution for CD4+ T cell antigen recognition and immunogenicity assessment, ImmuScope holds substantial promise for accelerating vaccine design and advancing personalized immunotherapy.Keywords
All Related Versions
Funding Information
- Department of Health | National Health and Medical Research Council (APP1144652, APP2036864, APP1127948)
- Major and Seed Inter-Disciplinary Research (IDR) projects awarded by Monash University.
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- National Natural Science Foundation of China (62372234, 62072243)
This publication has 77 references indexed in Scilit:
- Supervised contrastive learning enhances MHC-II peptide binding affinity predictionExpert Systems with Applications, 2025
- Cracking the code of adaptive immunity: The role of computational toolsCell Systems, 2024
- Principles and therapeutic applications of adaptive immunityCell, 2024
- Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunityCell Reports, 2023
- Principles of regulatory T cell functionImmunity, 2023
- Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen testsCell, 2022
- Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolboxImmunity, 2021
- Whole Slide Images are 2D Point Clouds: Context-Aware Survival Prediction Using Patch-Based Graph Convolutional Networks2021
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen PredictionCell, 2020
- MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen ProcessingCell Systems, 2020